Morgan Stanley Pure Tech Health PLC Put Options Transaction History
Morgan Stanley
- $1.39 Trillion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding PRTC
# of Institutions
5Shares Held
329KCall Options Held
0Put Options Held
0-
Birch Hill Investment Advisors LLC302KShares$5.72 Million0.27% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny45.3KShares$857,7520.0% of portfolio
-
Pentwater Capital Management LP Naples, FL24.1KShares$456,9030.01% of portfolio
-
Ubs Group Ag1.9KShares$36,0610.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$00.0% of portfolio
About PureTech Health plc
- Ticker PRTC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,888,500
- Market Cap $528M
- Description
- PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company offers KarXT targeting muscarinic acetylcholi...